Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

TOKE vs. MUAIX: which is better?

Bottom line

TOKE vs MUAIX: the short answer

TOKE (Cambria Cannabis ETF) and MUAIX (Ultra Short Income Portfolio) are both etfs.

MUAIX is cheaper at 0.4% vs 0.44% — a difference of $4.00 a year per $10,000 invested.

Over five years, MUAIX returned +3.4% a year vs −16.2% for TOKE (reporting dates differ).

Updated Nov 19, 2026

TOKE vs MUAIX side by side

TOKEMUAIX
TypeETFMutual fund
Fund familyCambriaMorgan Stanley
CategoryOtherOther
Expense ratio0.44%0.4%
Annual cost per $10k$44$40
10-yr cost on $10k (prospectus)$746$675
Max front loadNone—
12b-1 fee0%0.25%
1-yr return−7.4%+4.4%
5-yr return (annualized)−16.2%+3.4%
10-yr return (annualized)——
Best quarter+39.9%—
Worst quarter−32.6%—
Net assets (fund)—$19.6B
Number of holdings—235
Portfolio turnover33%—
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

TOKE and MUAIX share none of their top holdings.

TOKE top 10

    MUAIX top 10

    1. Credit Indust Et Comm Ny — 2.62%
    2. JPMorgan Securities LLC — 2.29%
    3. Citigroup Global Markets — 2.03%
    4. National Bank Of Canada — 1.79%
    5. Sumitomo Mitsui Banking — 1.53%
    6. JPMorgan Securities LLC — 1.53%
    7. Wells Fargo Securities LLC — 1.48%
    8. Protective Life Global — 1.34%
    9. TD Securities USA LLC — 1.34%
    10. UBS AG/London — 1.28%

    FAQ

    What is the difference between TOKE and MUAIX?
    TOKE (Cambria Cannabis ETF) and MUAIX (Ultra Short Income Portfolio) are both etfs. MUAIX is cheaper at 0.4% vs 0.44% — a difference of $4.00 a year per $10,000 invested.
    Which is cheaper, TOKE or MUAIX?
    MUAIX has the lower expense ratio (0.4%).
    Should I own both TOKE and MUAIX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.